It’s About Women Running Startups

Just before the holidays I had coffee with Anne, an ex MBA student running a fairly large product group at a search engine company, now out trying to raise money for her own startup. She had an interesting insight: existing content/media companies were having the same problem as hardware companies that rarely made the leap to new platforms. And she had a model for a new media company for mobile and wearables.women innovation I thought we were going to talk about her product progress, so I was a bit taken aback by her most pressing question, “Why is it so hard for a woman to still get taken seriously by a venture capitalist?”

I had lots of answers, but none of them good enough for either of us.

I had a better one when I came back from New York.

——
Entrepreneurship at Columbia
I was in New York last week teaching my annual 5-day version of the Lean LaunchPad class at the Columbia Business School. We had 130 students in 30 teams who got out of the classroom and did 2154 customer interviews in 5 days – a remarkable effort for 120 hours. Their amazing Lessons Learned presentations can be seen here.

In the last year entrepreneurship at Columbia has taken a pretty remarkable leap across the entire university. The Columbia Startup Lab is a visible symbol of how the university is making entrepreneurship an integral part of all colleges at the university.

New York Startups
The Columbia Startup Lab is in a building completely taken over by WeWork – a company that provides co-working spaces in 12 cities worldwide. I wandered through four full floors of SohoWest WeWork sticking my head into the random startups’ offices.

Looking at office after office of startups a few things stood out.

  • This was just one of the 14 WeWork co-working spaces in New York City– there are over 100 co-working spaces in New York
  • Michael Bloomberg has yet to get his due for engineering the New York entrepreneurial ecosystem
  • I was struck by something that had been slowly percolating through my head during my entire week – there are a higher percentage of women on the founding teams of New York City startups than in Silicon Valley

Women in New York Startups
This last point is definitely not a data-driven survey. However after spending a week teaching 130 entrepreneurship students, ~35% of them women, and then walking through ~100+ WeWork and TechSpace offices in New York, I get the impression that the number of women leading startups in New York is much higher than in the San Francisco Bay area.

When I mentioned this to my friends running the NYU and Columbia entrepreneurship programs, they looked at me like I just discovered that it gets dark at night. Their answer seemed to make sense: a higher percentage of startups in New York are focused on media, fashion, communications, real estate, financial tools – all the products of industries centered in NYC – and all are attempting to disrupt them with products that run on and are delivered by 21st century platforms. (Think of what Refinery29 is doing to Conde Nast.)

These are industries where women have had a history of leadership positions and more importantly, where young women entrepreneurs can find role models and mentors as their male counterparts do in Silicon Valley’s tech-centered, pay-it-forward culture.

This raises an interesting question: is the credibility of female entrepreneurs in the eyes of New York VC’s something about the venture firms, or is it about the industries they are funding?

One can make the case that New York venture capital industry is rooted in the 21st century not the 20th. While some venture firms have been around for awhile, perhaps the newer partners have a different model of what a successful founder looks like than their west coast peers.

Or perhaps it’s as simple as New York VC’s are funding startups that play on the disruption of New York’s key strengths in Media, Fashion, Finance and Real Estate, and the women founding New York startups have an existing track record in those industries, and pass a gender neutral “VC credibility” bar.

Correlation does not imply causation
Those bemoaning the dearth of women founders in Silicon Valley might want to see if there is a real disparity between the coasts or if it is just my selection bias?

If it’s real why?

  • Women founders already had leadership roles in the industries they’re about to disrupt?
  • Women can find existing role models?
  • Women have built a network of women mentors?

What role does the type of startup play?

  • Companies that get started and built in New York City tend to be applied technology
  • Companies that get started and built in Silicon Valley have historically focused on core technology

What role does venture capital play?

  • Is there any difference in funding women for old-line firms versus 21st century firms?
  • What role does industry segment play? (i.e. lots more women founders in media companies than you find in enterprise software companies.)
  • On the West Coast the history of successful startups is technology first, and perhaps VC’s weigh that more in what they want to see in founders.
  • Is it as simple as having credibility in the industry you want to startup in?

—–

I sent Anne, my student, an email when I returned, “You may want to take a trip to NY and pitch some of their VCs.”

Lessons Learned

  • Lots of entrepreneurial activity in NY
  • Different industry focus than in Silicon Valley – more media, finance, real estate
  • Women seem to be more represented as founders
  • If a NY bias toward women as founders is true, why? And what are the lessons for Silicon Valley?

The Art of the Minimal Viable Product. 2 Minutes to Find Out Why

The Art of the Minimal Viable Product.

2 Minutes to Find Out Why

If you can’t see the video click here

There Are 4 Types of Startups

There are 4 types of startups.

Which one are you?

If you can’t see the video click here

 

 

Getting out of the building…by staying in the building!

The landscape for how to turn life science and health care technologies into viable companies has changed more in the last 3 years than in the last 30. New approaches to translational medicine have emerged. Our Lean Launchpad® for Life Sciences is one of them. But a new class of life science/healthcare co-working and collaboration space is another.

———–

The National Institutes of Health recognizes that Life Science/Health Care commercialization has two components: the science/technology, and the business model. The Lean Launchpad® for Life Sciences (the I-Corps @ NIH) uses the Lean Startup Model to discover and validate the business model.

two parts to commericializationThe class provides Life Science/Health Care entrepreneurs with real world, hands-on learning on how to rapidly:

  • define clinical utility before spending millions of dollars
  • understand who their core and tertiary customers are, and the sales and marketing process required for initial clinical sales and downstream commercialization
  • assess intellectual property and regulatory risk before they design and build
  • know what data will be required by future partnerships/collaboration/purchases before doing the science
  • identify financing vehicles before you need them

This user/customer-centered approach is a huge step in the right direction in the life science/health care commercialization. However, one of the bottlenecks in actually doing Customer Discovery for medical devices/health care is testing how minimal viable products work in-context. Testing hypotheses with doctors, patients, payers, providers, purchasing departments, strategic partners is hard. It can involve traveling hundreds of miles and can consume months of time and loads of money. Scheduling time to look over a surgeon’s shoulder in an operating room is tough. Getting time to brainstorm with payers or experts in clinical trials is hard.

It would be great if there were a way to first test these hypotheses and minimal viable products in a realistic setting locally. Then after a first pass of validation, take them on the road and see if others agree.

A new life science/healthcare co-working and collaboration space
It looks like someone is actually pulling this together in a life science/healthcare co-working and collaboration space in Chicago called MATTER.

Co-working spaces seem to be evolving into the startup garages of the future. It’s a shared work environment (typically a floor of a building) where individuals (or small teams) rent space and work around other people but independently. Yet they share values and hopefully some synergy around topics of mutual interest (same customers, or technologies). Incubators are designed for teams with an idea. They add mentors and additional services and some offer free space in exchange for equity. Accelerators take teams with fairly focused ideas and offer a formal 3-4 month program of tutoring/mentoring with seed funding in exchange for equity.

The MATTER co-working space will have five unique things specifically for life science/healthcare companies:

  1. It’s focused exclusively on life science/health care (therapeutics, medical devices, diagnostics, digital health, health care IT, etc.)
  2. Key stakeholders in the broader healthcare ecosystem will be co-located under one roof: entrepreneurs, universities, established companies and strategic partners, providers, payers, hospitals, service providers, associations, advocacy groups, government and more.
  3. It will have a simulated procedure space that can be configured as an Operating Room, Emergency Room, Intensive Care Unit and other clinical/procedural settings. The space will include authentic lighting, equipment and other features that very closely resemble the look, sound and feel of these environments in the “real world”.
  4. It will have a clinician and patient studio configurable as a doctor’s office or a home care setting to simulate clinician and patient interactions. It will serve as a test bed for software, services and other technologies to improve the clinician/patient dynamic as well as improving workflows in the clinic.
  5. It will have a fabrication space where device startups can build minimum viable products and iterate on their designs while in the facility.

By building a co-working space that includes all of these stakeholders, MATTER allows startups (and companies) to get in front of customers and other members of the value chain first, before they leave the building.

The team at MATTER also realizes that facilities alone will not do the trick. In order to get the healthcare community to collaborate with each other to bring new ideas to market they will need some help to catalyze  the “co” part of co-working.

“The life sciences community is still warming-up to the value of customer development in the early stages of building new ventures”, says David Schonthal, MATTER Co-founder and Clinical Assistant Professor of entrepreneurship & innovation at the Kellogg School of Management. “Many of them aren’t yet clear on who their customer actually is – and as a result – what value they should be focused on creating. Essentially, through programming and content, we will need to teach many of our members the importance of understanding the needs of stakeholders and customers – we just aim to make it easier by bringing these people into the building.”

The procedure space and clinician and patient studio allow startups to test and demo medical devices, diagnostics, software and other technologies, with real clinicians, to validate hypotheses, their technologies, and discover the “unknown unknowns” that they wouldn’t learn until the product was used in a real clinical setting (meaning: after years of development and regulatory clearances).

But the real benefit for a Lean Startup is that unlike a traditional OR/ER, technologies/devices used in these spaces can be minimum viable products. They can be crude, non-sterile prototypes tested at any phase of their development (from sketch to machined parts), to answer any number of important questions that innovators might have about how, when, why and by whom a technology is used.

(Think of a startup building a diagnostic display designed for an operating room that discovered it was virtually unreadable and inaudible in the bright lights and loud sounds of a real operating room. Finding this out late in the development process can burn cash and time in a med tech company.)

MATTER is funded and supported by a broad range of private sector partners including established companies, providers, payers, service providers and others; as well as public sector support from the State of Illinois and the City of Chicago.

It Takes a Village
“This has been nearly a 4-year journey,” said Schonthal who prior to moving back to Chicago in 2011 had been working in healthcare venture capital in San Diego.

“One of the noticeable things about the San Diego health tech community is that it feels like a community. It has density,” he said. “People bump into each other, seek each other’s advice, make connections and collaborate on projects. In Chicago, despite having a lot of talent, companies and great research, we are a big, spread-out city. As a result we needed to design some of that density inside of MATTER so that serendipity can occur”.

Schonthal found that others in Chicago saw the vision. He enlisted the help of serial medical device entrepreneur Andrew Cittadine, biotech startup veteran Jeffery Aronin and Patrick Flavin and Steve Collens who was a major force behind the development of 1871 – Chicago’s digital co-working space. Together they recruited the support of the city, state and private industry who all agreed that frequent and early community collaboration to support young companies would be key to Chicago’s future in healthcare entrepreneurship.

Others Are Doing this As Well
MATTER is one of many organizations supporting life science/healthcare entrepreneurship across the country. In New York there’s Blueprint Health and Startup Health, in Denver there’s Stride and Princeton has Tiger Labs. Other incubators and accelerators in the health tech space include Health WildCatters in Dallas, RockHealth in Silicon Valley, Iron Yard in North Carolina, HealthBox Accelerator, Athena Health MDP in Boston and others. And probably the most important will be the Lean LaunchPad @ Life Science Angels class for early stage life science companies. Each of these has their own approach to supporting the creation of new ventures – but all are working to help young startups solve big problems.

Lessons Learned

  • Our knowledge of how to efficiently turn life science/health care technology into companies is rapidly increasing
  • Lean Methods are one such tool
  • Healthcare co-working and collaboration space is another

I-Corps at the NIH: Evidence-based Translational Medicine

If you’ve received this post in an email the embedded videos and powerpoint are best viewed on www.steveblank.com

We have learned a remarkable process that allow us to be highly focused, and we have learned a tool of trade we can now repeat. This has been of tremendous value to us.

Andrew Norris, Principal Investigator BCN Biosciences

Over the last three years the National Science Foundation I-Corps has taught over 700 teams of scientists how to commercialize their technology and how to fail less, increasing their odds for commercial success.

To see if this same curriculum would work for therapeutics, diagnostics, medical devices and digital health, we taught 26 teams at UCSF a life science version of the NSF curriculum. 110 researchers and clinicians, and Principal Investigators got out of the lab and hospital, and talked to 2,355 customers. (Details here)

For the last 10 weeks 19 teams in therapeutics, diagnostics and medical devices from the National Institutes of Health (from four of the largest institutes; NCINHBLI, NINDS, and NCATS) have gone through the I-Corps at NIH.

87 researchers and clinicians spoke to 2,120 customers, tested 695 hypotheses and pivoted 215 times. Every team spoke to over 100 customers.

Three Big Questions
The NIH teams weren’t just teams with ideas, they were fully formed companies with CEO’s and Principal Investigators who already had received a $150,000 grant from the NIH. With that SBIR-Phase 1 funding the teams were trying to establish the technical merit, feasibility, and commercial potential of their technology. Many will apply for a Phase II grant of up to $1 million to continue their R&D efforts.

Going into the class we had three questions:

  1. Could companies who were already pursuing a business model be convinced to revisit their key commercialization hypotheses – and iterate and pivot if needed?
  2. Was getting the Principal Investigators and CEO out of the building more effective than the traditional NIH model of bringing in outside consultants to do commercialization planning?
  3. Would our style of being relentlessly direct with senior scientists, who hadn’t had their work questioned in this fashion since their PhD orals, work with the NIH teams?

Evidence-based Translational Medicine
We’ve learned that information from 100 customers is just at the edge of having sufficient data to validate/invalidate a company’s business model hypotheses. As for whether you can/should push scientists past their comfort zone, the evidence is clear – there is no other program that gets teams anywhere close to talking to 100 customers. The reason? For entrepreneurs to get out of the building at this speed and scale is an unnatural act. It’s hard, there are lots of other demands on their time, etc. But we push and cajole hard, (our phrase is we’re relentlessly direct,) knowing that while they might find it uncomfortable the first three days of the class, they come out thanking us.

The experience is demanding but time and again we have seen I-Corps teams transform their business assumptions. This direct interaction with potential users and customers is essential to commercialize science (whether to license the technology or launch a startup.) This process can’t be outsourced. These teams saved years and millions of dollars for themselves, the NIH and the U.S. taxpayer. Evidence is now in-hand that with I-Corps@NIH the NIH has the most effective program for commercializing science.

Lessons Learned Day
Every week of this 10 week class, teams present a summary of what they learned from their customers interviews. For the final presentation each team created a two minute video about their 10-week journey and a 8-minute PowerPoint presentation to tell us where they started, what they learned, how they learned it, and where they’re going. This “Lessons Learned” presentation is much different than a traditional demo day. It gives us a sense of the learning, velocity and trajectory of the teams, rather than a demo day showing us how smart they are at a single point in time.

BCN Biosciences
This video from team BCN Biosciences describes what the intensity, urgency, velocity and trajectory of an I-Corps team felt like. Like a startup it’s relentless.

BCN is developing a drug that increases anti-cancer effect of radiation in lung cancer (and/or reduces normal tissue damage by at least 40%). They were certain their customers were Radiation Oncologists, that MOA data was needed, that they needed to have Phase 1 trial data to license their product, and needed >$5 million and 6 years. After 10 weeks and 100 interviews, they learned that these hypotheses were wrong.

If you can’t see the BCN Biosciences video click here

The I-Corps experience helped the BCN Bioscience team develop an entirely new set set of business model hypotheses – this time validated by customers and partners. The “money slides” for BCN Biosciences are slides 22 and 23.

If you can’t see the BCN Biosciences presentation click here

You Can’t Outsource Customer Discovery
What we hear time and again from the Principal Investigators is “I never would have known this” or “I wouldn’t have understood it if I hadn’t heard it myself.” Up until now the NIH model of commercialization treated a Principal Investigator as someone who can’t be bothered to get out of the building (let alone insist that it’s part of their job in commercialization.) In the 21st century using proxies to get out of the building is like using barbers as surgeons.

Clinacuity
While the Clinacuity video sounds like an ad for customer discovery, listen to what they said then look at their slides. This team really learned outside the building.


If you can’t see the Clinacuity video click here

Clinacuity’s technology automatically extracts data in real-time from clinical notes, (the narrative text documents in a Electronic Health Record,) and provides a summary in real time. Their diagrams of the healthcare customer segment in slides 15-18 were outstanding.

If you can’t see the Clinacuity presentation click here

GigaGen
The GigaGen team – making recombinant gamma globulin – holds the record for customer discovery – 163 customer interviews on multiple continents.

If you can’t see the GigaGen video click here

GigaGen’s learning on customer value proposition and who were the real stakeholders was a revelation. Their next-to-last slide on Activities, Resouces and Partners put the pieces together.

If you can’t see the GigaGen presentation click here

Affinity Therapeutics
Affinity came into class with a drug coated Arterial Venous Graft – graft narrowing is a big problem.

One of things we tell all the teams is that we’re not going to critique their clinical or biological hypotheses. Yet we know that by getting out of the building their interaction with customers might do just that. That’s what happened to Affinity.

If you can’t see the Affinity video click here

Affinity was a great example of a team that pivoted their MVP. They realized they might have a completely new product – Vascular wraps that can reduce graft infection.  See slides 17-23.

If you can’t see the Affinity presentation click here

Haro
Haro is making a drug for the treatment of high risk neuroblastoma, the most common extracranial cancer in infancy and childhood. On day 1 of the class I told the team, “Your presentation is different from the others – and not in a good way.”  That’s not how I described them in the final presentation.

If you can’t see the Haro video click here

After 120 interviews the Haro found that there are oncology organizations (NCI-funded clinical development partners) that will take Haro’s compound and develop it at their own expense and take it all the way into the clinic. This will save Haro tens of millions of dollars in development cost.  See slides 12 and 13.

If you can’t see the Haro presentation click here

Cardiax
Caridax is developing a neural stimulator to treat atrial fibrillation. Their video points out some of the common pitfalls in customer discovery. Great summary from Mark Bates, the Principal Investigator: “You don’t know what you don’t know. Scientific discovery is different than innovation. You as a prospective entrepreneur need this type of systematic vetting and analysis to know the difference.”

If you can’t see the Cardiax video click here

After 80 interviews they realized they were jumping to conclusions and imparting their bias into the process. Take a look at slides 8-11 and see their course correction.

If you can’t see the Cardiax presentation click here

The other 15 presentations were equally impressive. Each and every team stood up and delivered. And in ways that surprised themselves.

The Lean Startup approach (hypotheses testing outside the building,) was the first time clinicians and researchers understood that talking to customers didn’t require sales, marketing or an MBA – that they themselves could do a pretty good first pass. I-Corps at NIH just gave us more evidence that’s true.

The team videos and slides are on SlideShare here.

A Team Effort
This blog post may make it sound like there was no one else in the room but me and the teams. But nothing could be farther from the truth. The I-Corps@NIH teaching team was led by Edmund Pendleton. Allan May/Jonathan Fay taught medical devices, John Blaho/Bob Storey taught diagnostics and Karl Handelsman/Keith McGreggor taught therapeutics. Andre Marquis, Frank Rimalovski and Dean Chang provided additional expertise. Brandy Nagel was our tireless teaching assistant. Jerry Engel is the NSF I-Corps faculty director.

Special thanks to Paul Yock of Stanford Biodesign and Alexander Osterwalder for flying across the country/world to be part of the teaching team.

I created the I-Corps/Lean LaunchPad® syllabus/curriculum, and with guidance from Allan May, Karl Handelsman Abhas Gupta and Todd Morrill adapted it for Life Sciences/Health Care/Digital Health. The team from VentureWell provided the logistical support. The I-Corps program is run by the National Science Foundation (Babu Dasgupta, Don Millard and Anita LaSalle.) And of course none of this would be possible without the tremendous and enthusiastic support and encouragement of Michael Weingarten the director of the NIH/NCI SBIR program and his team.

Lessons Learned

  • The I-Corps/Lean LaunchPad curriculum works for therapeutics, diagnostics and device teams
  • Talking to 100 customers not only affected teams’ commercial hypotheses but also their biological and clinical assumptions
  • These teams saved years and millions of dollars for themselves, the NIH and the U.S. taxpayer
  • Evidence is now in-hand that the NIH has the most effective program for commercializing science
  • In the 21st century using proxies to get out of the building is like using barbers as surgeons

The Big Bang. The Lean LaunchPad explodes at University of Maryland

The University of Maryland is now integrating the Lean LaunchPad® into standard innovation and entrepreneurship courses across all 12 colleges within the University. Over 44 classes have embedded the business model canvas and/or Customer Discovery including a year-long course taken by every single one of its bioengineering majors.big bang 2

It’s made a big bang.

Here’s the story from Dean Chang, UMD’s Associate Vice President for Innovation and Entrepreneurship.

———————————————–

Two decades ago, Steve Blank completely changed the course and fortunes of a Stanford spinout startup called Immersion. I was lucky to be one of the very early people at Immersion and met Steve when he came on as one of our first board members. It was Steve who first brought Will Harvey to visit Immersion, which led to a strategic investment in There.com, Will’s stealth-mode but sure-fire, can’t-miss startup.

Present at the Creation
We didn’t know it at the time, but with that investment we had paid for front-row VIP seats to witness the origins of Customer Development and the Lean Startup. There.com is where Will first met and hired Eric Ries and had the painful and formative experiences that directly led to them starting over and co-founding IMVU while auditing Steve’s Lean LaunchPad course. With Eric Ries as the first practioner of Customer Development, Steve wrote Four Steps to the Epiphany, Eric wrote Lean Startup, and – BANG – Customer Development and Lean Startup were born!

Twenty years and 100,000’s of copies of those books later, my life has fortuitously intersected with Steve Blank once again now that we’ve both become educators. In my second go-around with Steve Blank, he’s still changing the course and fortunes of startups everywhere, but perhaps more profoundly, he’s now also changing the course of universities and students everywhere as a result of a program he developed with the National Science Foundation (NSF).

It’s a Capitol Idea
The DC, Maryland, and Virginia (DMV) region represents the most fertile science and technology region in the country with about $30 billion in federally-funded R&D. However, the region has historically underperformed in translating its enormous R&D output into impact.

When Steve and NSF created the I-Corps™ program in 2011, I approached Edmund Pendleton from University of Maryland, Jim Chung from George Washington University and Jack Lesko from Virginia Tech with the idea that together we could leverage the respective strengths of our institutions, and catalyze the region through I-Corps. In 2012, we applied for and then were awarded a grant from NSF to do just that. We created the DC I-Corps Regional Node to teach the Lean LaunchPad curriculum to top scientists, innovators, and students from around the country and from our region. Since 2013, DC I-Corps has trained over 150 teams with the kind of impact NSF and Steve envisioned when they launched the program. That impact is now accelerating with the DC I-Corps node’s addition of the #1 research university in the country (Johns Hopkins) in 2014.

UMD LLP Ecosystem

Teaching the Big Bang to Undergraduates
University of Maryland’s President Wallace Loh’s commitment to engage every student in all 12 colleges in innovation and entrepreneurship resulted in UMD aggressively leveraging its I-Corps and Lean LaunchPad experience inside undergraduate classrooms.

Our FedTech class pairs students with some of the most promising technologies from NASA, DOD and several other of the 87 federal labs located in the DMV region. Federal labs like DOE literally have tens of thousands of inventions that they’d like to have vetted for commercial potential, so FedTech students search for a repeatable and scalable business model for those fed lab technologies using the Lean LaunchPad framework. Students get course credit, a fantastic learning experience, and in some cases, even a job offer or career opportunity with the federal lab or with an industry contact made during interviews.

Elements of the business model canvas and/or discovery-based interviews of stakeholders have already been incorporated into 44 other classes at UMD. But the biggest impact of 2014 has been from incorporating the Lean LaunchPad curriculum into our signature, year-long senior capstone course in bioengineering. This means that every single University of Maryland student in the Fischell Department of Bioengineering is now required to not only design a real biomedical device but also take that design through rigorous, evidence-based Customer Development in order to graduate. 

Truth be told, we took a page out of Frank Rimalovski’s playbook at NYU and paid for Yang Tao to attend the Lean LaunchPad Educators Program.  He’s the professor who teaches the bioengineering capstone course, and he returned from Steve’s ranch inspired and determined to weave the Lean LaunchPad into the fabric of the capstone course. So what’s happened so far?

Impact of the Big Bang on University of Maryland Bioengineering
In this capstone course students visit the University of Maryland medical school and shadow doctors, nurses, and other hospital workers to learn about problems and needs, which is an ideal set up for customer interviews and discovery. They spend the year working with the doctors and the life sciences venture community to design devices and other solutions to those problems and needs.

Before Lean LaunchPad was added to the bioengineering capstone class, some beautiful devices were designed and manufactured with many students never knowing whether the value proposition for what they made was beneficial enough to all the right people to warrant adoption or if the customer segment they targeted was the right one and made financial sense.

Now the students spend time in customer discovery and learn why validating the business model for their device is so important. As they target the different parts of the canvas, they begin to understand how things like improved healthcare, purchasing, reimbursement, and regulatory must fit into a successful business model.

Some students will find that their device is an engineering marvel but would never fly in the market for reasons they weren’t even aware of until they did their “outside of the classroom” customer interviews. Co-instructor Martha Connolly thinks that’s a perfectly good outcome because they’ve still learned the process of designing and making a biomedical device but they’ve also learned equally valuable lessons from the Lean LaunchPad process that will be applicable in any future endeavors, whatever they may be.

The real proof of Lean LaunchPad’s impact is that the students are clamoring for it.

Can I Have More?
In fact, two UMD bioengineering students, Shawn Greenspan and Stephanie Cohen, went through the capstone course last year before Lean LaunchPad was integrated. They were so upset that they missed out on the Lean LaunchPad version of the course that they teamed up with Dr. Ron Samet, a very entrepreneurial professor of anesthesiology from the medical school, to take the class through this fall’s National Science Foundation I-Corps regional program taught in the D.C. area.

UMDAccording to Shawn and Stephanie, I-Corps taught them what they didn’t get from the traditional capstone course without Lean LaunchPad:

“I-Corps finally put us on the road to real customer discovery. Our initial business plan started with an incorrectly identified buyer, value propositions that were wrong, and guesses everywhere else. Fortunately after 67 interviews we now have a fully developed customer segment identifying each customer type, the key value propositions, and a developing revenue model.

We still have lots of work to do. The left side of our canvas has more questions than answers. Five weeks ago, that was scary to admit, but now we know where our answers lie: outside the building.”

This kind of feedback from students is particularly gratifying. Not only did the experience have the kind of impact we had hoped for, but it’s also turned into a potential career opportunity for Shawn and Stephanie as they’re completing their master’s programs.

What’s Next?
Four more Lean LaunchPad initiatives are either on tap or about to be scaled up:

Being a node instructor in the I-Corps @ NIH program has allowed me to work with some terrific experts in life sciences and healthcare ventures and spread that expertise to DC I-Corps and UMD programs. Next month, I’ll be a node instructor in NSF’s upcoming I-Corps for Learning program where we aim to teach STEM educators how to scale their teaching innovations to a wider audience. That experience should again result in great learnings to bring back and apply at UMD.

When I witnessed the Big Bang origins of Customer Development and Lean Startup 20 years ago during my first encounter with Steve Blank, I could not have guessed how fast it would impact the startup world, and now universities and students. If the past is prologue, the future is going to be fantastic!

Lessons Learned

  • University of Maryland has gone “all in” with the National Science Foundation Innovation Corps and discovery-based learning from stakeholders
  • I-Corps has been a great investment for the country. Regardless if they take startup path, students gain invaluable skills
  • Elective courses are great, but the big win comes from embedding Lean LaunchPad in existing required courses
  • Students can create job and career opportunities through their customer discovery interactions
  • The impact on life sciences and healthcare is evident in the UMD bioengineering program and in the NIH program
  • The Lean LaunchPad process is equally well-suited to areas like STEM education and government (e.g., fed labs, HHS)

K&S Ranch

In 1976 Saul Steinberg created the March 29th cover of the New Yorker and created a visual meme of a city who was completely self-absorbed.

Kirby Scudder, a neighbor on the California coast just did a poster of the view of Palo Alto as the center of universe.

Palo Alto poster Kirby has done several of these city posters here.  I thought it was a fun poster given its unique vantage point from the Pacific Ocean looking towards San Francisco Bay.

I was wondering where our ranch would be on the map until I looked closer.

K&S Ranch has been memorialized on the poster!

 

kands

 

Follow

Get every new post delivered to your Inbox.

Join 169,396 other followers